Mereo BioPharma Ratios (2017-2026) | MREO

Ratios Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin (Quarter) 61.89%127.30%80.00%
EBT Margin (Quarter) -19.46%-964.10%-2,923.20%
EBIT Margin (Quarter) -9.01%-712.80%-2,099.80%
EBITDA Margin (Quarter) -3.90%-500.60%-1,593.80%
Operating Margin (Quarter) -9.01%-712.80%-2,099.80%
Net Margin (Quarter) -19.46%-1,017.30%-2,923.20%
FCF Margin (Quarter) -86.16%-678.90%-1,530.20%
Efficiency
Assets Average (Quarter) 107.24M412.41M315.28M188.51M84.90M61.22M76.03M92.44M82.57M72.36M65.48M58.12M49.76M43.27M
Equity Average (Quarter) 62.56M47.90M47.03M52.19M52.62M46.69M60.74M3.06M-5.78M60.52M57.13M50.39M43.76M37.48M
Invested Capital (Quarter) 115.03M69.81M26.37M21.31M19.39M64.40M44.40M49.66M54.71M50.54M42.84M78.65M-72.54M60.97M60.08M54.18M46.60M40.92M34.05M
Asset Utilization Ratio (Quarter) 0.120.160.010.010.010.010.01
Leverage & Solvency
Interest Coverage Ratio (Quarter) -14.26-0.79-12.95-20.19-31.94-38.71-26.55114.54-62.23-437.46-357.68-364.78-438.30
Debt to Equity (Quarter) 0.330.660.25
Debt Ratio (Quarter) 0.220.320.240.260.110.13
Equity Ratio (Quarter) 0.650.490.500.760.770.82-0.820.800.880.870.870.890.84
Times Interest Earned (Quarter) -14.26-0.79-12.95-20.19-31.94-38.71-26.55114.54-62.23-437.46-357.68-364.78-438.30
Valuation
Enterprise Value (Quarter) -69.76M-35.44M-21.02M-30.99M-127.11M-66.08M-57.42M-48.66M-87.43M-80.52M-69.80M-62.50M-56.10M-48.70M-40.99M-36.22M
Return Ratios
Return on Sales (Quarter) 0.00%-0.10%-0.03%-0.38%-0.46%-0.29%-0.83%-0.84%
Return on Capital Employed (Quarter) -37.68%-53.58%-64.24%-50.13%15.81%14.74%20.51%21.57%-88.23%-101.57%
Return on Invested Capital (Quarter) -0.01%-0.01%-0.01%-0.13%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter) 0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.15%0.07%-0.01%-0.01%-0.01%-0.01%-0.01%